Concepedia
Statistics
Publications
29
Citations
1.3K
H-Index
20
Active since
2015
Affiliations
Aichi Cancer Center(Current)
Kobe City Medical Center General Hospital
Wakayama Medical University
Osaka International Cancer Institute
Kurashiki Central Hospital
Yuko Oya is an author at Aichi Cancer Center specializing in oncology, medicine, and lung cancer.
Publications per year
2015–2023
Differential Crizotinib Response Duration Among <i>ALK</i> Fusion Variants in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer
Tatsuya Yoshida, Yuko Oya, Kosuke Tanaka et al. · Journal of Clinical Oncology · 2016 · 257 citations
Medicine, Oncology, Pharmacology +17
Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
Yuko Oya, Tatsuya Yoshida, Hiroaki Kuroda et al. · Oncotarget · 2017 · 111 citations · Full text
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)
Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 89 citations
Medicine, Oncology, Pharmacology +12
EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma
Kosuke Tanaka, Toyoaki Hida, Yuko Oya et al. · Journal of Thoracic Oncology · 2015 · 68 citations · Full text
Medicine, Oncology, Surgery +16
Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i> -Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target
Kyung-A Song, Yasuyuki Hosono, Crystal Turner et al. · Clinical Cancer Research · 2018 · 66 citations
1–5 of 29